Dr. Anna Silke Hammerbacher, M.Sc., M.D.R.A., Ph.D. is a Vice President, Regulatory Strategy at SSI Strategy. They possess expertise in strategy, regulatory affairs, pharmaceutical industry, project management, biotechnology and 18 more skills. They is proficient in French. Colleagues describe them as "Anna is not just smart, talented, organised and great to work with, but she stands out from the crowd. We worked together on the same team on a very fast-moving development programme. Very soon after she joined the company and the team, she was instrumental to the delivery of regulatory advice from EMEA under extremely tight timelines. She led and managed the whole process successfully. She demonstrated outstanding leadership skills, initiative, integrity and strong project management skills from start to finish. We continued collaborating on other regulatory initiatives within the same programme, where Anna consistently performed very professionally and efficiently. Anna is a hard-working, ethical, motivated and efficient team member, very trustworthy and personable, a pleasure to work with. Anna is an expert in her field and having closely worked with her for over a year, I also had the opportunity to learn a lot from her. She will be an asset to any team that she joins." and "I wish to express my highest recommendation for Anna Limpert. Her ability to manage her projects has been outstanding. I have been consistently impressed by both Anna's attitude towards her work and her performance on the job. Anna was also highly respected by the people who work with her within the company as well as by external business partners. She possesses a strong knowledge in the field of regulatory affairs and is always looking to gaining even more knowledge. She has the analytical skills to diagnose problems and devise viable solutions. Anna would be a tremendous asset for any company."